Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • NORTH AMERICA BIOSURGERY MARKET FORECAST 2021-2028

NORTH AMERICA BIOSURGERY MARKET FORECAST 2021-2028

The North America biosurgery market is predicted to develop with a CAGR of 5.60% during the projected period of 2021 to 2028. The market growth of the region is attributed to the rising prevalence of chronic conditions like cancer and cardiovascular diseases, the growing aging population, the swift acceptance of technological advancements, and the increased funding and investment by the government.

NORTH AMERICA BIOSURGERY MARKET FORECAST 2021-2028

North America Market by Product ( Hemostatic Agents, Bone-graft Substitutes ( Synthetic Graft Extenders, Demineralized Bone Matrix, Bone Morphogenetic Proteins, Cell-based Matrices ) Surgical Sealing Agents ( Natural, Synthetic ) Soft-tissue Management ( Synthetic Mesh/patch, Natural Mesh/patch ) Anti-adhesive Agents, Staple Line Reinforcement ) Market by Source Type ( Natural, Synthetic ) Market by Application ( Orthopedic Surgery, Cardio and Thoracic Surgery, Neuro and Spine Surgery, General Surgery, Other Applications ) by Geography.

Request free sample

The North America biosurgery market is predicted to develop with a CAGR of 5.60% during the projected period of 2021 to 2028. The market growth of the region is attributed to the rising prevalence of chronic conditions like cancer and cardiovascular diseases, the growing aging population, the swift acceptance of technological advancements, and the increased funding and investment by the governmentnorth-america-biosurgery-market

To learn more about this report, request a free sample copy

The North America biosurgery market growth evaluation includes the study of the United States and Canada. The biosurgery market in the United States is the largest regional market globally and is expected to develop rapidly during the forecast years. The growth is primarily credited to the rising number of surgeries, the increasing research and development activities associated with biosurgery products, and the mounting geriatric population with chronic conditions.

On the other hand, the growing incidence of cardiovascular diseases (CVDs) has promoted the ascent in cardiovascular surgeries, consequently fueling the use of biosurgery products. As per the Global Health and Wellness Report published in 2018, around 40% of the United States’ adult population was diagnosed with cardiovascular disease, thereby generating an elevated demand for immediate and effective treatments. Moreover, according to the National Center for Biotechnology Information (NCBI), the United States also recorded a substantial rise in the number of surgical procedures over the last ten years. As a result, these factors are set to propel the market growth in North America over the forecasted period.

RTI Surgical Inc, headquartered in the United States, is a surgical implant firm that develops and commercializes metal, biologic, and synthetic implants. Its products include sports medicine implants, spine implants, orthobiologics, surgical specialties, and others. The company also provides bicortical allograft bone wedges, whole radius, cellular allogeneic bone graft, and dbm putties.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • PREVALENCE OF GERIATRIC POPULATION
        • ADVANCEMENTS IN TECHNOLOGY
        • INCIDENCE OF MUSCULOSKELETAL DISORDERS
        • SURGE IN RESEARCH AND DEVELOPMENT
      • KEY RESTRAINTS
        • HIGH COST OF SURGERIES
        • RISK ASSOCIATED WITH IMMUNE RESPONSE
        • GROWING POPULARITY OF MINIMALLY INVASIVE PROCEDURES
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON BIOSURGERY MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRY
        • INDUSTRY RIVALRY
      • KEY BUYING CRITERIA
      • KEY INSIGHTS
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY PRODUCT
      • HEMOSTATIC AGENTS
      • BONE-GRAFT SUBSTITUTES
        • SYNTHETIC GRAFT EXTENDERS
        • DEMINERALIZED BONE MATRIX
        • BONE MORPHOGENETIC PROTEINS
        • CELL-BASED MATRICES
      • SURGICAL SEALING AGENTS
        • NATURAL
        • SYNTHETIC
      • SOFT-TISSUE MANAGEMENT
        • SYNTHETIC MESH/PATCH
        • NATURAL MESH/PATCH
      • ANTI-ADHESIVE AGENTS
      • STAPLE LINE REINFORCEMENT
    3. MARKET BY SOURCE TYPE
      • NATURAL
      • SYNTHETIC
    4. MARKET BY APPLICATION
      • ORTHOPEDIC SURGERY
      • CARDIO AND THORACIC SURGERY
      • NEURO AND SPINE SURGERY
      • GENERAL SURGERY
      • OTHER APPLICATIONS
    5. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
      • COMPANY PROFILES
        • BAXTER INTERNATIONAL INC
        • B BRAUN MELSUNGEN AG
        • BECTON, DICKINSON AND COMPANY (C R BARD)
        • BETATECH MEDICAL
        • CSL LIMITED
        • CRYOLIFE INC
        • ETHICON INC (JOHNSON & JOHNSON)
        • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
        • MEDTRONIC PLC
        • RTI SURGICAL
        • SANOFI
        • SMITH & NEPHEW PLC
        • STRYKER CORPORATION
        • WRIGHT MEDICAL GROUP NV
        • ZIMMER BIOMET HOLDINGS INC

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – BIOSURGERY

    TABLE 2: NORTH AMERICA BIOSURGERY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: NORTH AMERICA BIOSURGERY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: NORTH AMERICA SURGICAL SEALING AGENTS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: NORTH AMERICA SURGICAL SEALING AGENTS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: NORTH AMERICA SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: NORTH AMERICA SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: NORTH AMERICA BIOSURGERY MARKET, BY SOURCE TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: NORTH AMERICA BIOSURGERY MARKET, BY SOURCE TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: NORTH AMERICA BIOSURGERY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: NORTH AMERICA BIOSURGERY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: NORTH AMERICA BIOSURGERY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: NORTH AMERICA BIOSURGERY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 16: LEADING PLAYERS OPERATING IN NORTH AMERICA BIOSURGERY MARKET

    TABLE 17: LIST OF MERGERS & ACQUISITIONS

    TABLE 18: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 29: LIST OF PARTNERSHIP & AGREEMENTS

    TABLE 20: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES 

    FIGURE LIST

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: NORTH AMERICA BIOSURGERY MARKET, BY PRODUCT, IN 2020

    FIGURE 6: NORTH AMERICA BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION)

    FIGURE 7: NORTH AMERICA BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION)

    FIGURE 8: NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $ MILLION)

    FIGURE 9: NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $ MILLION)

    FIGURE 10: NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $ MILLION)

    FIGURE 11: NORTH AMERICA BONE-GRAFT SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION)

    FIGURE 12: NORTH AMERICA BIOSURGERY MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION)

    FIGURE 13: NORTH AMERICA SURGICAL SEALING AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)

    FIGURE 14: NORTH AMERICA SURGICAL SEALING AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)

    FIGURE 15: NORTH AMERICA BIOSURGERY MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION)

    FIGURE 16: NORTH AMERICA SOFT-TISSUE MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $ MILLION)

    FIGURE 17: NORTH AMERICA SOFT-TISSUE MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION)

    FIGURE 18: NORTH AMERICA BIOSURGERY MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION)

    FIGURE 19: NORTH AMERICA BIOSURGERY MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION)

    FIGURE 20: NORTH AMERICA BIOSURGERY MARKET, BY SOURCE TYPE, IN 2020

    FIGURE 21: NORTH AMERICA BIOSURGERY MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)

    FIGURE 22: NORTH AMERICA BIOSURGERY MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)

    FIGURE 23: NORTH AMERICA BIOSURGERY MARKET, BY APPLICATION, IN 2020

    FIGURE 24: NORTH AMERICA BIOSURGERY MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)

    FIGURE 25: NORTH AMERICA BIOSURGERY MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION)

    FIGURE 26: NORTH AMERICA BIOSURGERY MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION)

    FIGURE 27: NORTH AMERICA BIOSURGERY MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION)

    FIGURE 28: NORTH AMERICA BIOSURGERY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 29: NORTH AMERICA BIOSURGERY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 30: UNITED STATES BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 31: CANADA BIOSURGERY MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. MARKET BY PRODUCT
      • HEMOSTATIC AGENTS
      • BONE-GRAFT SUBSTITUTES
        • SYNTHETIC GRAFT EXTENDERS
        • DEMINERALIZED BONE MATRIX
        • BONE MORPHOGENETIC PROTEINS
        • CELL-BASED MATRICES
      • SURGICAL SEALING AGENTS
        • NATURAL
        • SYNTHETIC
      • SOFT-TISSUE MANAGEMENT
        • SYNTHETIC MESH/PATCH
        • NATURAL MESH/PATCH
      • ANTI-ADHESIVE AGENTS
      • STAPLE LINE REINFORCEMENT
    2. MARKET BY SOURCE TYPE
      • NATURAL
      • SYNTHETIC
    3. MARKET BY APPLICATION
      • ORTHOPEDIC SURGERY
      • CARDIO AND THORACIC SURGERY
      • NEURO AND SPINE SURGERY
      • GENERAL SURGERY
      • OTHER APPLICATIONS

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now